XBiotech Inc. (XBIT) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for XBiotech Inc. (XBIT).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $2.92

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $89,024,088

Daily Volume: 0

Performance Metrics

1 Week: 0.69%

1 Month: -4.58%

3 Months: 4.66%

6 Months: -14.62%

1 Year: -52.98%

YTD: -26.08%

Company Details

Employees: 92

Sector: Health technology

Industry: Biotechnology

Country:

Details

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Selected stocks

TriplePoint Venture Growth BDC Corp. (TPVG)

Two Harbors Investment Corp (TWO)

Two Harbors Investments Corp 9.375% Senior Notes due 2030 (TWOD)